Faculty profile

Masoom Haider

Back to faculty

ProfessorDepartment of Medical ImagingUniversity of Toronto

Masoom Haider

Professor

Department of Medical Imaging

Temerty Faculty of Medicine

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
10 publications in the last five years, latest in 2026.
Senior (last) author on 1 recent paper, a sign of leading a research group.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

1,199

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Toronto profile.

Latest papers

External Validation and Comparison of Magnetic Resonance Imaging-based Risk Calculators for Detection of Clinically Significant Prostate Cancer: A Multi-institutional Study Incorporating Transrectal and Transperineal Biopsy Approaches.
European urology focus · 2026
Updated results of MR-assisted focal salvage HDR prostate brachytherapy: a prospective study.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2025
Is MRI ready to replace biopsy during active surveillance?
European radiology · 2024

All 35 publications

Latest funding

Development, multi-ancestry international validation, algorithmic audit, and prospective silent trial evaluation of PRISM - A globally accessible, patient-oriented artificial intelligence-based model to predict the presence of clinically significant prostate cancer
CIHR · 2023 · Co-investigator
$462,824
Creating patient-centred pathology reports (PAPRs) to empower patients with prostate cancer
CIHR · 2019 · Co-investigator
$99,815
Assessing the role and preventative or therapeutic effects of Faecalibacterium prausnitzii and other candidate bacteria in non-alcoholic fatty liver disease
CIHR · 2018 · Co-investigator
$25,000

All 11 grants and awards

35 publications.

External Validation and Comparison of Magnetic Resonance Imaging-based Risk Calculators for Detection of Clinically Significant Prostate Cancer: A Multi-institutional Study Incorporating Transrectal and Transperineal Biopsy Approaches.

Zlotta AR, Taborek A, Kwong JCC, Wang A, Boulakia N, Yin LB, Zhang KK, Nguyen DD, Srigley JR, der Kwast TV, Prendeville S, Booth R, Shahid A, Ringa M, Ali A, Diamond I, Bruni S, Klotz LH, Perlis N, Fleshner N, Finelli A, Diamand R, Ghai S, Haider M, Buckley R, Feifer A, Mian BM, Kulkarni GS

European urology focus2026

DOI: 10.1016/j.euf.2026.06.027 PMID: 42763233

Updated results of MR-assisted focal salvage HDR prostate brachytherapy: a prospective study.

Paulin G, Morton G, Loblaw A, Tseng CL, Corkum M, Murgic J, Ravi A, Davidson M, Wronski M, Paudel M, Haider M, Deabreu A, Zhang L, Chung HT

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology20252 citationsOpen Access

DOI: 10.1016/j.radonc.2025.111091 PMID: 40789422

Is MRI ready to replace biopsy during active surveillance?

Dias AB, Woo S, Leni R, Rajwa P, Kasivisvanathan V, Ghai S, Haider M, Gandaglia G, Brembilla G

European radiology202413 citationsOpen Access

DOI: 10.1007/s00330-024-10863-9 PMID: 38965093

Re: Francesco Giganti, Louise Dickinson, Clement Orczyk, et al. Prostate Imaging After Focal Ablation (PI-FAB): A Proposal for a Scoring System for Multiparametric MRI of the Prostate After Focal Therapy. Eur Urol Oncol. 2023;6:629-634.

Abreu-Gomez J, Haider M, Ghai S

European urology oncology2024

DOI: 10.1016/j.euo.2023.07.015 PMID: 37620233

The role of [18F]-DCFPyL PET/MRI radiomics for pathological grade group prediction in prostate cancer.

Basso Dias A, Mirshahvalad SA, Ortega C, Perlis N, Berlin A, van der Kwast T, Ghai S, Jhaveri K, Metser U, Haider M, Avery L, Veit-Haibach P

European journal of nuclear medicine and molecular imaging202318 citations

DOI: 10.1007/s00259-023-06136-0 PMID: 36809425

T2-weighted MRI radiomics in high-grade intramedullary osteosarcoma: predictive accuracy in assessing histologic response to chemotherapy, overall survival, and disease-free survival.

White LM, Atinga A, Naraghi AM, Lajkosz K, Wunder JS, Ferguson P, Tsoi K, Griffin A, Haider M

Skeletal radiology2023Senior author

DOI: 10.1007/s00256-022-04098-2 PMID: 35778618

Prostate Cancer Patients Under Active Surveillance with a Suspicious Magnetic Resonance Imaging Finding Are at Increased Risk of Needing Treatment: Results of the Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium

Jonathan Olivier, Weiyu Li, Daan Nieboer, Jozien Helleman, Monique J. Roobol, Vincent J. Gnanapragasam, Mark Frydenberg, Mikio Sugimoto, Peter Carroll, Todd Matthew Morgan, R. Valdagni, Jose Rubio‐Briones, Grégoire Robert, Phillip D. Stricker, Andrew D. Hayen, Ivo G. Schoots, Masoom A. Haider, Caroline M. Moore, Brian T. Denton, Arnauld Villers, Bruce J. Trock, Behfar Ehdaie, Peter Carroll, Christopher Paul Filson, Christopher J. Logothetis, Todd Matthew Morgan, Laurence H. Klotz, Tom Pickles, Eric Hyndman, Caroline M. Moore, et al. (93 authors)

European Urology Open Science202229 citationsOpen Access

DOI: 10.1016/j.euros.2021.11.006 PMID: 35024633

A Prospective Study of Magnetic Resonance Imaging-guided Focal Salvage High-dose-Rate Brachytherapy for Radiorecurrent Prostate Cancer: Updated Results of 30 Patients.

Corkum MT, Morton G, Loblaw DA, Tseng CL, Murgic J, Ravi A, Davidson MTM, Wronski M, Haider M, Chung HT

Practical radiation oncology202220 citations

DOI: 10.1016/j.prro.2022.05.018 PMID: 35718075

CT Radiomics and Whole Genome Sequencing in Patients with Pancreatic Ductal Adenocarcinoma: Predictive Radiogenomics Modeling.

Hinzpeter R, Kulanthaivelu R, Kohan A, Avery L, Pham NA, Ortega C, Metser U, Haider M, Veit-Haibach P

Cancers202214 citationsOpen Access

DOI: 10.3390/cancers14246224 PMID: 36551709

A protocol for the VISION study: An indiVidual patient data meta-analysis of randomised trials comparing MRI-targeted biopsy to standard transrectal ultraSound guided bIopsy in the detection of prOstate cancer

Kasivisvanathan V, Chan VW-S, Clement KD, Levis B, Haider M, Agarwal R, Emberton M, Pond GR, Takwoingi Y, Klotz L

PLoS ONE20227 citationsOpen Access

DOI: 10.1371/journal.pone.0263345

Development, multi-ancestry international validation, algorithmic audit, and prospective silent trial evaluation of PRISM - A globally accessible, patient-oriented artificial intelligence-based model to predict the presence of clinically significant prostate cancer

Co-investigatorCIHR2023Project Grant

Principal investigators: Zlotta, Alexandre R

Keywords: Artificial Intelligence; Clinically Significant Prostate Cancer; Early Diagnosis; Health Informatics; Prostate Cancer; Risk Calculator; Urology

$462,824

Creating patient-centred pathology reports (PAPRs) to empower patients with prostate cancer

Co-investigatorCIHR2019Catalyst Grant: Patient-Oriented Research

Principal investigators: Perlis, Nathan; Papadakos, Janet K

Keywords: Prostate Cancer

$99,815

Assessing the role and preventative or therapeutic effects of Faecalibacterium prausnitzii and other candidate bacteria in non-alcoholic fatty liver disease

Co-investigatorCIHR2018Team Grant: Canadian Microbiome Initiative 2: Research Teams - LOI

Principal investigators: Allard, Johane P; Bhat, Mamatha; Gaisano, Herbert Y; Hota, Susy S; Philpott, Dana J; Poutanen, Susan M

Keywords: Fecal Microbiota Transplant; Human; Intestinal Microbiome; Liver Transplant; Metabolic Syndrome; Mice; Non-Alcoholic Fatty Liver Disease; Nutrition; Prebiotics; Probiotics

$25,000

Porphyrin Nanomedicine for Cancer Imaging and Therapy

Co-investigatorCIHR2016Foundation Grant

Principal investigators: Zheng, Gang

Keywords: Blood Brain Barrier; Cancer Imaging; Image-Guided Therapy; Immunotherapy; Lipoprotein; Microbubbles; Nanoparticle; Photodynamic Therapy; Photothermal Therapy; Radiotherapy

$3,300,088

Refining Genotype-Phenotype Correlation of ADPKD

Co-investigatorCIHR2012Operating Grant

Principal investigators: Pei, York P

Keywords: Genotype-Phenotype Correlation; Kidney Volume Imaging; Polycystic Kidney Disease

$283,302

The Host-Microbiome Research Network

Co-investigatorCFI2012Innovation Fund: Leading Edge Fund (2012 competition)

Principal investigators: Philpott, Dana

Keywords: Analysis of microbiome, impact of microbiome on health and disease, modulation of microbiome as a therapeutic option, analysis of host-microbe interactions germ-free incubators, MRI, high-resolution microscopy/flow cytometry, mass spec

$6,000,000

MRI-Guided Focal Ablation of Prostate Cancerous Tissue

Co-investigatorNSERC2010Collaborative Health Research Projects

Principal investigators: Goldenberg, AndrewAvi

$187,500

Characterization of Intestinal Microbiota and its Interaction with Diet in Diabetes Type 2, Non-Alcoholic Fatty Liver Disease and Colon Cancer

Co-investigatorCIHR2009Canadian Microbiome Initiative - LOI

Principal investigators: Allard, Johane P; Jenkins, David J; Krause, Denis O

Keywords: Colon Cancer; Diabetes Type 2; Microbiota; Non-Alcoholic Fatty Liver Disease; Nutrition; Obesity

3D ultrasound-guided trans-perineal focal prostate therapy platform

Co-investigatorCIHR2008Operating Grant

Principal investigators: Fenster, Aaron

Keywords: Image-Guided Therapy; Prostate Focal Therapy; Prostate Therapy; Ultrasound Imaging

$631,813

FIRN-II. Enhancing the University of Toronto Imaging Research Network - From discovery through treatment, delivering the promise of molecular imaging and advanced image guided therapy.

Co-investigatorCFI2006Innovation Fund: Leading Edge Fund 2006

Principal investigators: Houle, Sylvain

Keywords: Positron emision tomography, magnetic resonance imaging, ultrasound, radiochemistry, medical imaging, image guided therapy, minimally invasive therapy, molecular imaging, MR-guided focussed ultrasound therapy

$2,200,000

From public funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998 with their latest competition results, the Canada Foundation for Innovation, Genome Canada, the Canadian Space Agency, Canada Research Chairs, the Fonds de recherche du Québec, Ontario research funding, Michael Smith Health Research BC, the Canadian Cancer Society, Heart & Stroke and Brain Canada.

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Masoom Haider

Research

Latest papers

Latest funding

External Validation and Comparison of Magnetic Resonance Imaging-based Risk Calculators for Detection of Clinically Significant Prostate Cancer: A Multi-institutional Study Incorporating Transrectal and Transperineal Biopsy Approaches.

Updated results of MR-assisted focal salvage HDR prostate brachytherapy: a prospective study.

Is MRI ready to replace biopsy during active surveillance?

Re: Francesco Giganti, Louise Dickinson, Clement Orczyk, et al. Prostate Imaging After Focal Ablation (PI-FAB): A Proposal for a Scoring System for Multiparametric MRI of the Prostate After Focal Therapy. Eur Urol Oncol. 2023;6:629-634.

The role of [18F]-DCFPyL PET/MRI radiomics for pathological grade group prediction in prostate cancer.

T2-weighted MRI radiomics in high-grade intramedullary osteosarcoma: predictive accuracy in assessing histologic response to chemotherapy, overall survival, and disease-free survival.

Prostate Cancer Patients Under Active Surveillance with a Suspicious Magnetic Resonance Imaging Finding Are at Increased Risk of Needing Treatment: Results of the Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium

A Prospective Study of Magnetic Resonance Imaging-guided Focal Salvage High-dose-Rate Brachytherapy for Radiorecurrent Prostate Cancer: Updated Results of 30 Patients.

CT Radiomics and Whole Genome Sequencing in Patients with Pancreatic Ductal Adenocarcinoma: Predictive Radiogenomics Modeling.

A protocol for the VISION study: An indiVidual patient data meta-analysis of randomised trials comparing MRI-targeted biopsy to standard transrectal ultraSound guided bIopsy in the detection of prOstate cancer

Development, multi-ancestry international validation, algorithmic audit, and prospective silent trial evaluation of PRISM - A globally accessible, patient-oriented artificial intelligence-based model to predict the presence of clinically significant prostate cancer

Creating patient-centred pathology reports (PAPRs) to empower patients with prostate cancer

Assessing the role and preventative or therapeutic effects of Faecalibacterium prausnitzii and other candidate bacteria in non-alcoholic fatty liver disease

Porphyrin Nanomedicine for Cancer Imaging and Therapy

Refining Genotype-Phenotype Correlation of ADPKD

The Host-Microbiome Research Network

MRI-Guided Focal Ablation of Prostate Cancerous Tissue

Characterization of Intestinal Microbiota and its Interaction with Diet in Diabetes Type 2, Non-Alcoholic Fatty Liver Disease and Colon Cancer

3D ultrasound-guided trans-perineal focal prostate therapy platform

FIRN-II. Enhancing the University of Toronto Imaging Research Network - From discovery through treatment, delivering the promise of molecular imaging and advanced image guided therapy.

Frequent collaborators

Laurence Klotz

Sangeet Ghai

Andrew Loblaw

Gerard Morton

Linda Sugar

Chia-Lin Tseng

Neil Fleshner

Nathan Perlis

Patrick Veit-Haibach

Gregory Pond

Kartik Jhaveri

Ur Metser

Antonio Finelli

John Trachtenberg

David Berman

Laura Dawson

Alejandro Berlin

Robert Crump

Adriano Dias

Trafford Crump

Girish Kulkarni

Jaydeep Halankar

John Kachura

Farzad Khalvati